Tumor-derived angiogenic factors, particularly VEGF-A, PLGF, and angiopoietin-2, contribute not only to aberrant vascularization but also to immune suppression by promoting regulatory T-cells (Tregs), impairing dendritic cell maturation, and reducing T-cell infiltration29,.30 This evidence concerns the gene ANGPT2 and neoplasm.